Seroprevalance of antibodies specific for severe fever with thrombocytopenia syndrome virus and the discovery of asymptomatic infections in Henan Province, China

Abstract

Background

Severe fever with thrombocytopenia syndrome (SFTS) is a severe emerging disease caused by SFTS virus (SFTSV), and the geographical distribution of SFTS has been increasing throughout China in recent years. To assess SFTSV-specific antibody seroprevalence, a cross-sectional study was conducted for healthy people in high SFTS endemic areas of Henan province in 2016.

Methods

This study used a stratified random sampling method to select 14 natural villages as the investigation sites. From April to May 2016, participants completed a questionnaire survey and serum samples were collected. All serum samples were subjected to ELISA to detect SFTSV-specific IgM and IgG. All IgM-positive samples were further tested by real-time RT-PCR, and isolation of virus from serum was attempted. Any participant who was IgM-positive was followed up with a month later to confirm health status.

Results

In total, 1463 healthy people participated in this study. The average seropositive rates for SFTSV-specific IgG and IgM were 10.46% (153/1463) and 0.82% (12/1463), respectively. IgM was detected in 12 individuals, and SFTSV RNA was detected in six of them. Virus was isolated from five of the six SFTSV RNA-positive individuals, and phylogenetic analyses revealed that all five isolates belonged to SFTSV group A. No IgM-positive participants exhibited any symptoms or other signs of illness at the one-month follow up.

Conclusions

This study identified a relatively high incidence of SFTSV-specific antibody seropositivity in healthy people in Xinyang city. Moreover, our data provide the first evidence for asymptomatic SFTSV infections, which may have significant implications for SFTS outbreak control.

About the Authors:

Yanhua Du

Contributed equally to this work with: Yanhua Du, Ningning Cheng

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft

Affiliations Henan Center for Disease Control and Prevention, Zhengzhou, China, Henan Key Laboratory of Pathogenic Microorganisms, Zhengzhou, China

Ningning Cheng

Contributed equally to this work with: Yanhua Du, Ningning Cheng

Roles Data curation, Investigation, Methodology

Affiliation: Kaifeng Center for Disease Control and Prevention, Kaifeng, China

Yi Li

Roles Investigation, Methodology

Affiliations Henan Center for Disease Control and Prevention, Zhengzhou, China, Henan Key Laboratory of Pathogenic Microorganisms, Zhengzhou, China

Haifeng Wang

Roles Investigation

Affiliation: Henan Center for Disease Control and Prevention, Zhengzhou, China

Aiguo You

Roles Investigation, Software

Affiliation: Henan Center for Disease Control and Prevention, Zhengzhou, China

Jia Su

Roles Supervision

Affiliation: Henan Center for Disease Control and Prevention, Zhengzhou, China

Yifei Nie

Roles Investigation

Affiliation: Henan Center for Disease Control and Prevention, Zhengzhou, China

Hongxia Ma

Roles Methodology

Affiliations Henan Center for Disease Control and Prevention, Zhengzhou, China, Henan Key Laboratory of Pathogenic Microorganisms, Zhengzhou, China

Bianli Xu

Roles Conceptualization, Data curation, Project administration, Resources, Visualization

* E-mail: [email protected] (BX); [email protected] (XH)

Affiliations Henan Center for Disease Control and Prevention, Zhengzhou, China, Henan Key Laboratory of Pathogenic Microorganisms, Zhengzhou, China

Xueyong Huang

Roles Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Writing – review & editing

* E-mail: [email protected] (BX); [email protected] (XH)

Affiliations Henan Center for Disease Control and Prevention, Zhengzhou, China, Henan Key Laboratory of Pathogenic Microorganisms, Zhengzhou, China, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang, China

ORCID logo http://orcid.org/0000-0001-8995-9274

Introduction

Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne emerging infectious disease that first appeared in eastern China in 2006 [1–3]. Since then, SFTS cases have been reported in almost 25 provinces of China as well as other countries, including Japan, Korea, and Vietnam [4–6]. The major clinical features of disease include fever, thrombocytopenia, leukocytopenia, gastrointestinal symptoms, and neurological symptoms, as well as other, less specific clinical manifestations [7,8]. The average case fatality rate of SFTS was about 30% when this disease was firstly reported [1]. In 2009, SFTS virus (SFTSV) was identified from a patient located in Xinyang, Henan, China as the etiologic agent of SFTS [9]. The public health threat posed by SFTSV was highlighted in 2016 and 2017, the World Health Organization listed the virus as priority pathogen requiring urgent attention [10].

SFTSV is prevalent mainly in seven central-eastern provinces of China including Henan, Hubei, Anhui, Jiangsu, Zhejiang, Shandong, and Liaoning. According to the National Notifiable Diseases Surveillance System (an administrative database developed by China CDC), more than 85% of SFTS cases were reported in rural regions of these seven provinces, with the highest number reported in Henan province since 2010 [11,12]. Xinyang city of Henan province located around Dabie mountain is a high endemic area, where more than 95% of SFTS cases come from Henan province [13]. Therefore, a cross-sectional study was performed in rural areas of Xinyang city to identify the actual seroprevalence of SFTSV.

Methods

Study design

A cross-sectional investigation was conducted in Xinyang city by random cluster sampling. The city was divided into 10 administrative counties/districts. First, one county (Xin) and one district (Pingqiao) were selected and then one town was selected from each (Balifan and Pengjiawan, respectively). From these two towns, fourteen natural villages that had previously reported cases of SFTS were selected and healthy individuals from these villages were recruited for the study.

The survey participants were selected using strict criteria. For the purposes of this study, a healthy person was defined as someone who had lived in the area for more than 1 year, was aged 2 years or older, and had no history of fever or other discomfort for the two weeks prior to enrollment. People who had been diagnosed with SFTS in the past were excluded from the study. Previous studies have shown SFTSV seroprevalence to range between 7.2% and 10.5% in healthy people with no reported symptoms associated with SFTS [14]. Thus, assuming a 7% incidence of SFTS, the minimum sample size required for 80% power and a two tailed 5% level of significance in this study was calculated to be 1276.

Field Investigation and sample collection

The survey was carried out from April to May 2016. A questionnaire was used to collect information on name, gender, age, occupation, home address, and history of fever or SFTS. Serum samples were collected from survey subjects who met the inclusion criteria. All samples were transported frozen to the pathogen laboratory of the Henan Center for Disease Control and Prevention (Henan CDC).

Indirect Enzyme-linked Immunosorbent Assays (ELISA)

For the indirect IgG ELISA, 96-well plates were coated with 50 ng recombinant SFTSV nucleoprotein per well overnight at 4°C. Recombinant SFTSV nucleoprotein was expressed and purified as previously described [15]. Plates were washed three times with wash buffer (0.01M PBS, 0.05% Tween 20). Serum samples were diluted at 1:400 in 5% nonfat milk with PBS-T, and 50 μL of each sample were added to each well. Plates were incubated at 37°C for 1 hour and then washed with wash buffer before wells were treated with 1:30,000 diluted horseradish peroxidase-conjugated goat anti-human IgG (American Qualex, California, USA) at 37°C for 1 hour. After washing, 100 μL H2O2-ABTS substrate (Kirkegaard & Perry Laboratories Inc., Gaithersburg, MD) was added to each well, and plates were incubated for 30 min at 37°C. Absorbance was measured at 405 nm (including negative and blank controls). The test results were determined to be valid if the criteria for the positive control and the negative controls were fulfilled. Calculation of the cut-off value was the mean absorbance value for negative controls times 2.1; if the mean absorbance value for negative controls was lower than 0.05, then the value 0.05 was used. Positive/negative determination of samples was performed using the cut-off value.

The procedure for the indirect IgM ELISAs was similar to that for the indirect IgG ELISAs, except that the detection of bound IgM was done with 1:10,000 diluted horseradish peroxidase-conjugated goat anti-human IgM (American Qualex, Califonia, USA).

Detection of SFTSV by real-time RT-PCR

Total RNA was extracted from SFTSV-IgM positive samples using a QIAamp viral RNA mini Kit (Qiagen, Germany), following the manufacturer’s instructions. The real-time RT-PCR assay using PCR Diagnostic Kit for SFTSV RNA (BGI-GBI, China) was performed as previously described [16]. Data were analyzed using the software supplied by the manufacturer.

Virus isolation and sequencing

SFTSV RT-PCR positive serum samples (100 μL) were used to inoculate Vero cells for virus isolation. Following inoculation, Vero cell monolayers were incubated for 7–10 days at 37°C and 5% CO2 in MEM/1% fetal calf serum and monitored daily for cytopathic effect (CPE). Virus-positive cells were identified over the course of three passages by the presence of CPE as well as real-time RT-PCR, as previously described [17]. Samples were judged as negative and excluded if they remained negative for CPE and real-time RT-PCR even after three passages. The whole genome sequence of SFTSV isolates was amplified using primers described previously [18,19]. PCR products were sent to Jinsirui Biotech Co., Ltd (Nanjing, China) for DNA sequencing using an automated ABI 3730 DNA Sequencer. In order to confirm results of real-time RT-PCR, the PCR products were also sent to Takara Biomedical Technology Co., Ltd. (Beijing, China) for DNA sequencing by using plasmid cloning technique.

Phylogenetic analysis

The genomes of SFTSV isolates were compiled using the SeqMan program in the DNAStar package, version 7.1.0. (Lasergene, DNAStar, Inc. Madison, WI, USA). Molecular phylogenetic analysis was conducted using the maximum likelihood (ML) method based on the Kimura 2-parameter model in MEGA 5.05 software (http://www.megasoftware.net/) [20]. Thirty SFTSV sequences obtained from GenBank were analyzed together with our newly generated SFTSV genomes, and phylogenetic trees were constructed in order to understand the evolutionary relationships of SFTSV isolates.

Statistical analysis

All epidemiologic and laboratory data were double-entered with the EpiData 3.1 software. All statistical analyses were performed using SAS v9.13 (SAS Institute Inc., Cary, NC). Count data was analyzed by χ2 test or Fisher’s exact test. A difference was considered significant when the P-value was less than 0.05.

Ethics statement

This research was approved by the Institutional Review Board at the Center for Disease Control and Prevention of Henan Province (NO.2016-KY-002-02). The methods were carried out in accordance with the principles of the Declaration of Helsinki. All adult participants signed the written informed consent and agreed to use their serum samples for research. In the case of child participants, a parent or legal guardian signed the written informed consent on their child’s behalf.

Results

Survey subjects and serum samples

A total of 1463 healthy persons were surveyed in high SFTS epidemic areas: 768 from Xin county and 695 from Pingqiao district. Among the survey subjects, 409 were males and 1054 were females, with a male–female sex ratio of 0.39. The median age of the survey subjects was 60 years (range: 2–92). Serum samples were collected from every survey subject.

SFTSV IgG and IgM prevalence and isolation of virus

All serum samples were tested for SFTSV IgG and IgM by indirect ELISA. From the 1463 individuals, 153 were positive for IgG and 12 were positive for IgM, giving seropositivity rates of 10.46% (153/1463) and 0.82% (12/1463), respectively. The median age of these individuals was 60 years (range, 32–73), and the sex ratio was 1 to 2 (4 males and 8 females). There were no statistically significant differences in IgG or IgM seropositivity rates between gender or among different age groups (Table 1). Among the 12 IgM-positive samples, six were positive for SFTSV RNA by real-time RT-PCR and we isolated SFTSV from five (Table 2). Notably, the viral RNA levels increased over three passages for these five isolates, indicating a productive infection (Table 2). The 12 IgM-positive individuals were followed up with one month after initial sampling. None reported a fever or any other typical clinical presentation associated with SFTS, including headache, muscle aches, nausea, or vomiting, either at the time of follow-up or during the preceding one-month period. Serum samples taken at the follow-up visit were negative for SFTSV RNA and IgM but positive for IgG. Together these data suggest that these 12 individuals experienced an asymptomatic SFTSV infection.

[Figure omitted. See PDF.]

Table 1. Demographic characteristic of SFTSV IgG and IgM seropositive in healthy people.

https://doi.org/10.1371/journal.pntd.0007242.t001

[Figure omitted. See PDF.]

Table 2. Results of ELISA and real-time RT-PCR in 12 IgM seropositive healthy persons.

https://doi.org/10.1371/journal.pntd.0007242.t002

Molecular characterization of SFTSV strains

The complete genomes of the five SFTSV isolates obtained from participant serum samples were successfully sequenced, and all sequences were submitted to GenBank (Accession numbers: MF045948- MF045952, MF045955- MF045959, MF045962- MF045965 and MF045968). The nucleotide sequences of the five SFTSV isolates were closely related to each other, with 99.95% to 99.98% nucleotide identity for the complete L segments, 99.94% to 99.97% nucleotide identity for the complete M segments, and 99.94% to 100.00% nucleotide identity for the complete S segments. The five samples isolated SFTSV strains were tested by the real-time PCR and the PCR products were sequenced by using plasmid cloning technique. The results show that 4 PCR products were sequenced successfully. The nucleotide sequences of PCR products were 100% similar to SFTSV isolated strains in this study (Table 2).

Phylogenetic analyses were performed using these five sequences as well as 30 additional full-length SFTSV sequences downloaded from GenBank and representing virus from different regions and times. The analysis revealed four major sub-lineages, referred to as genotypes A, B, C, and D [12], and showed that the L, M, and S sequences from the five isolates obtained in this study belonged to SFTSV genotype A (Fig 1).

[Figure omitted. See PDF.]

Fig 1. Phylogenetic analysis of SFTSV strains isolated from healthy people from Xinyang, Henan compared with other SFTSV.

The phylogenetic tree was constructed by the maximum likelihood method with the MEGA5 software. The reliability values indicated at the branch nodes were determined using 1,000 bootstrap replications. Isolated SFTSV strains in this study were labeled by black solid diamonds. Phylogenetic relationship of SFTSV with other bunyaviruses, based on the complete L, M, S segment sequences, are shown in panel (A), (B), (C), respectively.

https://doi.org/10.1371/journal.pntd.0007242.g001

Discussion

SFTSV is an expanding global public health threat due to its high mortality and its increased incidence in several countries around the world [21,22]. A recent report showed that an estimated 8.3% of SFTS cases went undiagnosed in high endemic areas [23], possibly because the cases lacked typical clinical features of disease, such as fever or thrombocytopenia. If true, these data suggest that the actual incidence of SFTS may be much higher than currently reported. Therefore, in an effort to better understand the dynamics of STFTS, we performed a cross-sectional study to evaluate the seroprevalence of SFTSV-specific antibodies in healthy individuals in Xinyang rural region.

In this study, we investigated 1463 healthy persons in 14 natural villages of Xinyang city from April to May 2016. The average seropositive rate of SFTSV-specific IgG was 10.46% (153/1463). To our surprise, 12 individuals were positive for IgM, and six of these were also positive for SFTSV RNA, suggesting that these people were experiencing an active SFTSV infection. Indeed, we isolated SFTSV from five of the six people. Interestingly, upon a one-month follow-up visit, none of the 12 individuals reported having experienced any symptoms consistent with SFTS (although we cannot rule out the confounding role that recall bias may have played). To our knowledge, this is the first report of the isolation of SFTSV from otherwise healthy individuals, and it suggests the existence of asymptomatic SFTSV infections, which may have significant effects on the dynamics of SFTS outbreaks. Future work should focus on the underlying factors that contribute to the development of asymptomatic SFTSV infections, such as host genetic background [24], as well as the degree to which asymptomatic cases may infect other individuals. Indeed, additional control measures may be necessary in high endemic regions to prevent asymptomatic individuals from propagating SFTS outbreaks.

The predominant cause of the epidemic in this area. A previous Bayesian evolutionary analysis suggested that SFTSV likely originated 50–225 years ago in areas around Dabie mountain, which borders Henan, Anhui and Hubei provinces [25]. The majority of the SFTSV strains from mainland China belong to genotypes A, B and D, while genotype C is less frequent and mainly found in Jiangsu and Shandong provinces [26]. Although genotypes A, B, and D circulate in Henan province, genotype A has always been predominant [12]. Considering the predominance of this genotype in Henan province, as well as the fact that all participants from whom SFTSV was isolated lived in the same town (Balifan), it is not surprising that the nucleotide sequences of SFTSV isolates were highly homologous, and belonged to genotype A.

Previous epidemiologic studies have examined the seroprevalence of SFTSV-specific antibodies among healthy individuals in China and have reported seropositive rates ranging from 0.23% to 9.17%, depending on the region surveyed [27]. Indeed, a previous study in Xinyang city—the same geographical regions surveyed in the present study—determined a seropositive rate of 6.59% from 2011 to 2013 [28]. This value is slightly less than ours and may suggest that the incidence of SFTS is increasing in the area, perhaps due to the increased distribution of SFTSV or increased exposure of people to the virus [29]. Notably, however, past seroprevalence investigations have been limited by small sample sizes or survey locations in urban (as opposed to rural) areas, and sampling methods may differ between studies, thus limiting comparisons.Further research is therefore required to continue to improve our understanding of SFTS in China and elsewhere.

Supporting information

S1 Checklist. STROBE statement—Checklist of items that should be included in reports of observational studies.

https://doi.org/10.1371/journal.pntd.0007242.s001

(DOC)

Citation: Du Y, Cheng N, Li Y, Wang H, You A, Su J, et al. (2019) Seroprevalance of antibodies specific for severe fever with thrombocytopenia syndrome virus and the discovery of asymptomatic infections in Henan Province, China. PLoS Negl Trop Dis 13(11): e0007242. https://doi.org/10.1371/journal.pntd.0007242

References

1. Liu Q, He B, Huang SY, Wei F, Zhu XQ (2014) Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis 14: 763–772. pmid:24837566

2. Liu S, Chai C, Wang C, Amer S, Lv H, et al. (2014) Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev Med Virol 24: 90–102. pmid:24310908

3. Li D (2013) A highly pathogenic new bunyavirus emerged in China. Emerg Microbes Infect 2: e1. pmid:26038435

4. Liu K, Zhou H, Sun RX, Yao HW, Li Y, et al. (2015) A national assessment of the epidemiology of severe fever with thrombocytopenia syndrome, China. Sci Rep 5: 9679. pmid:25902910

5. Zhan J, Wang Q, Cheng J, Hu B, Li J, et al. (2017) Current status of severe fever with thrombocytopenia syndrome in China. Virol Sin 32: 51–62. pmid:28251515

6. Tran XC, Yun Y, Van An L, Kim SH, Thao NTP, et al. (2019) Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam. Emerg Infect Dis 25: 1029–1031. pmid:31002059

7. Guo CT, Lu QB, Ding SJ, Hu CY, Hu JG, et al. (2016) Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis. Epidemiol Infect 144: 1345–1354. pmid:26542444

8. Kang K, Tang XY, Xu BL, You AG, Huang XY, et al. (2012) [Analysis of the epidemic characteristics of fever and thrombocytopenia syndrome in Henan province, 2007–2011]. Zhonghua Yu Fang Yi Xue Za Zhi 46: 106–109. pmid:22490189

9. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, et al. (2011) Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 364: 1523–1532. pmid:21410387

10. Asokan GV, Ramadhan T, Ahmed E, Sanad H (2019) WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain. Oman Med J 34: 184–193. pmid:31110624

11. Qu J, Zhang S, Li JD, Li DX (2013) [Epidemic situation and surveillance on SFTS in China, 2011–2012]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 27: 257–259. pmid:24579468

12. Huang X, Du Y, Hu X, Ma H, Wang H, et al. (2014) Epidemiological and etiological characteristics of fever, thrombocytopenia and leukopenia syndrome in Henan Province, China, 2011–2012. PLoS One 9: e91166. pmid:24633131

13. Xu B, Liu L, Huang X, Ma H, Zhang Y, et al. (2011) Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog 7: e1002369. pmid:22114553

14. Ni H, Yang F, Li Y, Liu W, Jiao S, et al. (2015) Apodemus agrarius is a potential natural host of severe fever with thrombocytopenia syndrome (SFTS)-causing novel bunyavirus. J Clin Virol 71: 82–88. pmid:26322483

15. Yu F, Du Y, Huang X, Ma H, Xu B, et al. (2015) Application of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for the detection of SFTSV-specific human IgG and IgM antibodies by indirect ELISA. Virol J 12: 117. pmid:26239826

16. Huang X, Liu L, Du Y, Ma H, Mu Y, et al. (2013) Detection of a novel bunyavirus associated with fever, thrombocytopenia and leukopenia syndrome in Henan Province, China, using real-time reverse transcription PCR. J Med Microbiol 62: 1060–1064. pmid:23618800

17. Huang XY, Du YH, Li XL, Ma H, Man RQ, et al. (2012) [Establishment of indirect immunofluorescence assay (IFA) for detection of IgG antibody against new bunyavirus]. Zhonghua Yu Fang Yi Xue Za Zhi 46: 165–168. pmid:22490201

18. Du YH, Huang XY, Deng WB, Ma HX, Ma H, et al. (2012) [Culture, isolation and identification of new bunyavirus in African green monkey kidney(Vero) cells]. Zhonghua Yu Fang Yi Xue Za Zhi 46: 169–172. pmid:22490202

19. Zhang YZ, Zhou DJ, Xiong Y, Chen XP, He YW, et al. (2011) Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Zhonghua Liu Xing Bing Xue Za Zhi 32: 209–220. pmid:21457654

20. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739. pmid:21546353

21. Sun J, Lu L, Wu H, Yang J, Ren J, et al. (2017) The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011–2016. Sci Rep 7: 9236. pmid:28835633

22. Li Y, Zhou H, Mu D, Yin W, Yu H (2015) [Epidemiological analysis on severe fever with thrombocytopenia syndrome under the national surveillance data from 2011 to 2014, China]. Zhonghua Liu Xing Bing Xue Za Zhi 36: 598–602. pmid:26564632

23. Huang X, Wang S, Wang X, Lyu Y, Jiang M, et al. (2018) Estimation of the incidence of severe fever with thrombocytopenia syndrome in high endemic areas in China: an inpatient-based retrospective study. BMC Infect Dis 18: 66. pmid:29402229

24. Sun J, Tang Y, Ling F, Chang Y, Ye X, et al. (2015) Genetic Susceptibility Is One of the Determinants for Severe Fever with Thrombocytopenia Syndrome Virus Infection and Fatal Outcome: An Epidemiological Investigation. PLoS One 10: e0132968. pmid:26207638

25. Liu JW, Zhao L, Luo LM, Liu MM, Sun Y, et al. (2016) Molecular Evolution and Spatial Transmission of Severe Fever with Thrombocytopenia Syndrome Virus Based on Complete Genome Sequences. PLoS One 11: e0151677. pmid:26999664

26. Li Z, Hu J, Cui L, Hong Y, Liu J, et al. (2017) Increased Prevalence of Severe Fever with Thrombocytopenia Syndrome in Eastern China Clustered with Multiple Genotypes and Reasserted Virus during 2010–2015. Sci Rep 7: 6503. pmid:28747674

27. Li P, Tong ZD, Li KF, Tang A, Dai YX, et al. (2017) Seroprevalence of severe fever with thrombocytopenia syndrome virus in China: A systematic review and meta-analysis. PLoS One 12: e0175592. pmid:28399161

28. Hu C, Guo C, Yang Z, Wang L, Hu J, et al. (2015) The severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) antibody in a highly endemic region from 2011 to 2013: a comparative serological study. Am J Trop Med Hyg 92: 479–481. pmid:25624404

29. You AG, Du YH, Huang XY, Wang HF, Su J, et al. (2017) [Characteristics of spatiotemporal distribution on severe fever with thrombocytopenia syndrome in Henan province]. Zhonghua Liu Xing Bing Xue Za Zhi 38: 1386–1389. pmid:29060985